Carregando...

Evaluating Outcomes of Mother-Infant Pairs Using Dolutegravir for Treatment of HIV During Pregnancy

BACKGROUND: Dolutegravir (DTG) is a highly efficacious and well tolerated antiretroviral (ART) for the treatment of HIV infection. Although on the preferred treatment list for people living with HIV, it is not a treatment option for pregnant women because data on efficacy, tolerability during pregna...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Principais autores: Sibliss, Kedesha, Kirby, Olivia, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Momplaisir, Florence
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631320/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!